BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8692637)

  • 1. Medication for children with attentional disorders. American Academy of Pediatrics Committee on Children With Disabilities and Committee on Drugs.
    Pediatrics; 1996 Aug; 98(2 Pt 1):301-4. PubMed ID: 8692637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Academy of Pediatrics Committee on Children with Disabilities, Committee on Drugs: Medication for children with an attention deficit disorder.
    Pediatrics; 1987 Nov; 80(5):758-60. PubMed ID: 3670981
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
    Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
    Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of action of drugs used to treat attention-deficit hyperactivity disorder: focus on catecholamine receptor pharmacology.
    Shenker A
    Adv Pediatr; 1992; 39():337-82. PubMed ID: 1359740
    [No Abstract]   [Full Text] [Related]  

  • 6. ADHD treatment across the life cycle.
    Spencer TJ
    J Clin Psychiatry; 2004; 65 Suppl 3():22-6. PubMed ID: 15046532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopharmacology of ADHD in adolescents.
    Greydanus DE; Sloane MA; Rappley MD
    Adolesc Med; 2002 Oct; 13(3):599-624. PubMed ID: 12270803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications.
    Wolraich ML; Wibbelsman CJ; Brown TE; Evans SW; Gotlieb EM; Knight JR; Ross EC; Shubiner HH; Wender EH; Wilens T
    Pediatrics; 2005 Jun; 115(6):1734-46. PubMed ID: 15930238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AAP guideline on treatment of children with ADHD. American Academy of Pediatrics.
    Chatfield J;
    Am Fam Physician; 2002 Feb; 65(4):726, 728. PubMed ID: 11871686
    [No Abstract]   [Full Text] [Related]  

  • 11. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention deficit hyperactivity disorder across the lifespan: the child, adolescent, and adult.
    Greydanus DE; Pratt HD; Patel DR
    Dis Mon; 2007 Feb; 53(2):70-131. PubMed ID: 17386306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Children with attention deficit disorders with hyperactivity; the role of drugs in treatment].
    van der Gaag RJ; Buitelaar JK
    Ned Tijdschr Geneeskd; 1991 Jul; 135(28):1261-6. PubMed ID: 1861762
    [No Abstract]   [Full Text] [Related]  

  • 14. The stimulants revisited.
    Wilens TE; Spencer TJ
    Child Adolesc Psychiatr Clin N Am; 2000 Jul; 9(3):573-603, viii. PubMed ID: 10944658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic alternatives to psychostimulants for the treatment of attention-deficit/hyperactivity disorder.
    Popper CW
    Child Adolesc Psychiatr Clin N Am; 2000 Jul; 9(3):605-46, viii. PubMed ID: 10944659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of treatment refractory attention-deficit/hyperactivity disorder in children and adolescents.
    Wagner KD
    Psychopharmacol Bull; 2002; 36(1):130-42. PubMed ID: 12397852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit hyperactivity disorder.
    Higgins ES
    J Fam Pract; 1999 Jan; 48(1):15-20. PubMed ID: 9934377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case study: adverse effects of smoking marijuana while receiving tricyclic antidepressants.
    Wilens TE; Biederman J; Spencer TJ
    J Am Acad Child Adolesc Psychiatry; 1997 Jan; 36(1):45-8. PubMed ID: 9000780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial.
    Mohammadi MR; Kashani L; Akhondzadeh S; Izadian ES; Ohadinia S
    J Clin Pharm Ther; 2004 Apr; 29(2):139-44. PubMed ID: 15068402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.